Emmanuel Martínez Moreno

ORCID: 0000-0002-3521-7010
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Acute Myeloid Leukemia Research
  • Acute Lymphoblastic Leukemia research
  • Hematological disorders and diagnostics
  • Breast Cancer Treatment Studies
  • Tuberculosis Research and Epidemiology
  • Pharmaceutical studies and practices
  • Diagnosis and treatment of tuberculosis
  • HER2/EGFR in Cancer Research
  • Chronic Lymphocytic Leukemia Research
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Immune Cell Function and Interaction
  • Childhood Cancer Survivors' Quality of Life
  • Cancer Treatment and Pharmacology
  • Platelet Disorders and Treatments
  • Blood groups and transfusion

Hospital General de México
2022-2024

Instituto Nacional de Cancerología
2019

University of Santo Tomas Hospital
2013

Alterations in blood cell counts are the most prominent and recurrent clinical findings among patients suffering from both acute chronic liver disease. These changes an important marker of failure often play a key role evaluation management these patients. Together with prolongation coagulation tests, thrombocytopenia is common disorder individuals. This condition, as well leukopenia, largely attributable to hypersplenism, which spleen retains destroys cells, including platelets. However,...

10.24265/horizmed.2024.v24n2.13 article EN cc-by Horizonte Médico (Lima) 2024-06-27

IL-15 is a proinflammatory myokine essential for activating NK cells and CD8+ T lymphocytes, its overexpression has been related to reducing overall survivorship in patients with acute lymphoblastic leukemia (ALL). Physical exercise shown be safe, feasible, beneficial hematological cancers. Exercise requires the activation of muscles that secrete cytokines, such as IL-15, causing immune mobilization. The objective was compare outcomes two training routines on survival prognosis adult...

10.3390/jfmk9010004 article EN cc-by Journal of Functional Morphology and Kinesiology 2023-12-21
Coming Soon ...